Abstract
Endotoxins, when entering the circulation in sufficient amounts, elicit multiple effects that can lead to shock and death. Besides these detrimental effects, endotoxins in minute concentrations may nonspecifically contribute to regulate the steady state of host defense. Moreover, various experimental approaches have shown, already in the early years of endotoxin research, that injection of small amounts of extracted endotoxins can induce beneficial effects, such as tolerance to the pyrogenic and lethal effects of endotoxin, nonspecific resistance to microbial infections and irradiation disease, stimulation of hematopoiesis, as well as tumor regression. These beneficial effects of endotoxins have been reviewed recently (13).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Belosevic, M., Davis, C. E., Meltzer, M. S., and Nacy, C. A., 1988, Regulation of activated macrophage antimicrobial activities, Identification of lymphokines that cooperate with IFN- Y for induction of resistance to infection. J. Immunol. 141: 890.
Broxmeyer, H. E., Williams, D. E., Lu, L., Cooper, S., Anderson, S. L., Beyer, G. S., Hoffman, R., and Rubin, B. Y., 1986, The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-Y, J. Immunol. 136: 4487.
Czuprynski, C. J., and Brown, J. F., 1987, Recombinant murine interleukin-1 enhancement of nonspecific antibacterial resistance. Infect. Immun. 55: 2061.
Dinarello, C. A., 1987, The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol. Letters 16: 227.
Dinarello, C. A., Cannon, J. G., and Wolff, S. M., 1988, New concepts on the pathogenesis of fever, in: “Perspectives on Bacterial Pathogenesis and Host Defense,” B. Urbaschek, ed., The University of Chicago Press, Chicago.
Ditter, B., Becker, K.-P., Urbaschek, R., and Urbaschek, B., 1983, Quantitativer Endotoxinnachweis. Automatisierter, kinetischer Limulus-Amobozyten-Lysat Mikrotiter-Test mit Messung probenabhingiger Interferenzen. ArzneimittelForsch/Drug Res. 33: 681.
Fraker, D. L., Stovroff, M. C., Merino, M. J., and Norton, J. A., 1988, Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J. Exp. Med. 168: 95.
Friedman, H., Blanchard, D. K., Newton, C., Klein, T., Stewart, II, W., Keler, T., and Nowotny, A., 1987, Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures. J. Biol. Resp. Modif. 6: 664.
Greer, G. G., and Rietschel, E. Th., 1978. Inverse relationship between the susceptibility of lipoplysaccharide (lipid A)-pretreated mice to the hypothermic and lethal effect of lipopolysaccharide. Infect. Immun. 20: 366.
Greisman, S. E., 1983, Induction of endotoxin tolerance, in: “Beneficial Effects of Endotoxins,” A. Nowotny, ed., Plenum Press, New York.
McCuskey, R. S., Urbaschek, R., McCuskey, P. A., and Urbaschek, B., 1983, In vivo microscopic observations of the responses of Kupffer cells and the hepatic microcirculation to Mycobacterium bovis BCG alone and in combination with endotoxin. Infect. Immun. 42: 362.
Neta, R., Douches, S. D., and Oppenheim, J. J., 1986, Interleukin-1 is a radioprotector. J. Immunol. 136: 2483.
Nowotny, A., 1983, “Beneficial Effects of Endotoxins,” Plenum Press New York
Ozaki, Y., Ohashi, T., Minami, A., and Nakamura, S.-I., 1987, Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-la, Infect. Immun. 55: 1436.
Rietschel, E. Th., Schade, U., Jensen, M., Wollenweber, H. W., Lüüderitz, O., and Greisman, S. E., 1982, Bacterial endotoxins: Chemical structure, biological activity and role in septicaemia. Scand. J. Infect. Dis. 31 (Suppl.): 8.
Rothstein, J. L., and Schreiber, H., 1988, Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. (USA) 85: 607.
Urbaschek, B., Ditter, B., Becker, K.-P., and Urbaschek, R., 1984, Protective effects and role of endotoxin in experimental septicemia. Circ. Shock 14: 209.
Urbaschek, R., and Urbaschek, B., 1982, Aspects of beneficial endotoxinmediated effects. Kiin. Wochenschr. 60: 746.
Urbaschek, R., and Urbaschek, B., 1983, Ability of post-endotoxin serum from BCG-infected mice to induce nonspecific resistance and stimulation of granulopoiesis. Infect. Immun. 39: 1488.
Urbaschek, R., Männel, D. N., Mergenhagen, S. E., and Urbaschek, B., 1986, The role of post-endotoxin serum components from BCG infected mice in the protection of compromised hosts, in: “Immunobiology and Immunopharmacology of Bacterial Endotoxins,” A—Szentivanyi, H. Friedman, and A. Nowotny,Plenum Press, New York.
Urbaschek, R., Iannel, D. N., and Urbaschek, B., 1987, Tumor necrosis factor induced stimulation of granulopoiesis and radioprotection. Lymph. Res. 6: 179.
Urbaschek, R., and Urbaschek, B., 1987, Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects. Rev. Infect. Dis. 9: S607.
Urbaschek, R., Urbaschek, B., and Ribi, E., 1985, Induction of nonspecific resistance, endotoxin tolerance and colony-stimulating activity (CSA) by nontoxic LPS components. Fed. Proc. 44: 1490.
Vogel, S. N., Douches, S. D., Kaufman, E. N., Neta, R., 1987, Induction of colony stimulating factor in vivo by recombinant interleukin 1 a and recombinant tumor necrosis factor a. J. Immunol. 138: 2143.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Urbaschek, R., Urbaschek, B. (1990). The Mediation of Endotoxin-Induced Beneficial Effects by Cytokines. In: Friedman, H., Klein, T.W., Nakano, M., Nowotny, A. (eds) Endotoxin. Advances in Experimental Medicine and Biology, vol 256. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5140-6_48
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5140-6_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5142-0
Online ISBN: 978-1-4757-5140-6
eBook Packages: Springer Book Archive